JAK1/2 Inhibition Fights MPNs Without Blocking Oncogenes
In a groundbreaking study published in Nature Communications, researchers have upended previous assumptions about the mechanisms underlying the therapeutic effects of JAK1/2 inhibitors in treating...
















